{"url_path":"/sec/aura/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-11","source_url":"https://www.sec.gov/Archives/edgar/data/1501796/0001193125-26-216808-index.html","accession_number":"0001193125-26-216808","cik":"0001501796","ticker":"AURA","issuer_name":"Aura Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1501796/0001193125-26-216808-index.html","primary_entity_key":"0001501796","primary_entity_name":"Aura Biosciences, Inc."},"word_count":39,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\n(a) Recent Sales of Unregistered Equity Securities\n\nNone.\n\n(b) Use of Proceeds from the Initial Public Offering of Common Stock\n\nNone.\n\n(c) Issuer Purchases of Equity Securities\n\nNone."}